SLC22A2 (O15244) variants and mutations
SLC22A2 (also known as O15244) is a human protein-coding gene encoding a solute carrier family 22 member 2 protein. It transports organic cations from blood into renal proximal-tubule cells and is important for elimination of drugs such as metformin and cisplatin. Functional variants and drug interactions can alter renal drug clearance and toxicity. This analysis covers 976 SLC22A2 variants and mutations. Of these, 91% have computational variant effect predictions. Disease context includes chronic kidney disease, prostate carcinoma, and coronary artery disorder. Example SLC22A2 variants include M1?, P2S, and V5G.
Variant analysis overview
- Gene: SLC22A2
- Protein: O15244
- UniProt accession: O15244
- Organism: Homo sapiens
- Variants analyzed: 976
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 759 unspecified-consequence records; 106 missense variants; 74 synonymous variants; 21 frameshift variants; 1 in-frame deletions; 4 splice-region variants; 6 stop-gained variants; 5 substitution
- Prediction scores: 891 variants have prediction scores (91% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: chronic kidney disease, prostate carcinoma, coronary artery disorder, kidney failure, cardiovascular disorder, type 2 diabetes mellitus, nervous system disorder, Precordial pain, psychiatric disorder, vascular disorder, renal osteodystrophy, angina pectoris.
Protein structure and variant hotspots
- Protein features: 12 transmembrane segments; 1 post-translational modification sites.
- Structural context: 433 variants have structural context.
- PTM context: 1 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable SLC22A2 variants
Examples include M1?, P2S, V5G, V5M, D6E, D6G, G12R, G13E. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- P2S (p.Pro2Ser), TOPMed rs1346240034, gnomAD rs1346240034, REVEL 0.15, CADD 17.90
- V5G (p.Val5Gly), gnomAD rs1783323890, REVEL 0.55, CADD 24.10
- V5M (p.Val5Met), ExAC rs767239723, TOPMed rs767239723, gnomAD rs767239723, REVEL 0.19, CADD 6.52
- D6E (p.Asp6Glu), ESP rs139039970, ExAC rs139039970, TOPMed rs139039970, gnomAD rs139039970, REVEL 0.39, CADD 16.50
- D6G (p.Asp6Gly), Ensembl rs1783323835, SIFT 0.01
- G12R (p.Gly12Arg), rs200254093, NCI-TCGA Cosmic COSV6526, ExAC rs200254093, TOPMed rs200254093, REVEL 0.13, CADD 13.90, Variant assessed as somatic; moderate impact.
- G13E (p.Gly13Glu), ExAC rs760038413, TOPMed rs760038413, gnomAD rs760038413, REVEL 0.73, CADD 23.80
- G13V (p.Gly13Val), ExAC rs760038413, TOPMed rs760038413, gnomAD rs760038413, REVEL 0.75, CADD 23.70
- G13W (p.Gly13Trp), NCI-TCGA TCGA novel, REVEL 0.65, CADD 24.30, Variant assessed as somatic; moderate impact.
- E14* (p.Glu14Ter), TOPMed rs1220789527, gnomAD rs1220789527, CADD 34.00
- E14A (p.Glu14Ala), Ensembl rs1783323162
- E14D (p.Glu14Asp), NCI-TCGA TCGA novel, SIFT 0.07, Variant assessed as somatic; moderate impact.
- E14K (p.Glu14Lys), TOPMed rs1220789527, gnomAD rs1220789527, REVEL 0.33, CADD 18.10
- H16Q (p.His16Gln), ExAC rs776630141, gnomAD rs776630141, REVEL 0.15, CADD 17.20
- F17C (p.Phe17Cys), TOPMed rs1318646520, gnomAD rs1318646520, REVEL 0.25, CADD 21.90
- F18I (p.Phe18Ile), gnomAD rs1196922904, REVEL 0.68, CADD 25.70
- F18S (p.Phe18Ser), NCI-TCGA TCGA novel, SIFT 0.24, Variant assessed as somatic; high impact.
- F18V (p.Phe18Val), gnomAD rs1196922904, REVEL 0.70, CADD 25.50
- Q19* (p.Gln19Ter), NCI-TCGA Cosmic COSV6526, CADD 37.00, Variant assessed as somatic; high impact.
- K20N (p.Lys20Asn), ExAC rs760788572, TOPMed rs760788572, gnomAD rs760788572, REVEL 0.51, CADD 18.80
- M22I (p.Met22Ile), gnomAD rs1294952425
- M22L (p.Met22Leu), TOPMed rs1783322736, MetaLR 0.03, MetaSVM -0.97
- F23I (p.Phe23Ile), TOPMed rs1453433228, gnomAD rs1453433228, REVEL 0.54, CADD 25.70
- L25F (p.Leu25Phe), ExAC rs773286352, gnomAD rs773286352, REVEL 0.14, CADD 14.50
- A27S (p.Ala27Ser), gnomAD rs1434995384, REVEL 0.24, CADD 0.05
- L28V (p.Leu28Val), Ensembl rs1783322292
- S30L (p.Ser30Leu), rs774203224, ExAC rs774203224, TOPMed rs774203224, gnomAD rs774203224, REVEL 0.53, CADD 25.10, Variant assessed as somatic; moderate impact.
- S30W (p.Ser30Trp), ExAC rs774203224, TOPMed rs774203224, gnomAD rs774203224, REVEL 0.59, CADD 25.40
- A31S (p.Ala31Ser), ExAC rs749224875, TOPMed rs749224875, gnomAD rs749224875, REVEL 0.22, CADD 10.90, Uncertain significance
- A31T (p.Ala31Thr), cosmic curated COSV65268, ExAC rs749224875, TOPMed rs749224875, gnomAD rs749224875, REVEL 0.23, CADD 7.69, Uncertain significance, not specified
- T32N (p.Thr32Asn), Ensembl rs1583403794, MetaLR 0.09, MetaSVM -1.06
- F33L (p.Phe33Leu), 1000Genomes rs568261775, ExAC rs568261775, TOPMed rs568261775, gnomAD rs568261775, MetaLR 0.27, MetaSVM -0.67
- A34V (p.Ala34Val), NCI-TCGA TCGA novel, REVEL 0.36, CADD 22.50, Variant assessed as somatic; moderate impact.
- P35R (p.Pro35Arg), ExAC rs780658045, TOPMed rs780658045, gnomAD rs780658045, REVEL 0.50, CADD 23.10
- P35S (p.Pro35Ser), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10087, REVEL 0.22, CADD 16.20, Variant assessed as somatic; moderate impact.
- Y37H (p.Tyr37His), TOPMed rs1783321496
- V38M (p.Val38Met), cosmic curated COSV10821, NCI-TCGA TCGA novel, REVEL 0.41, CADD 23.00, Variant assessed as somatic; moderate impact.
- G39S (p.Gly39Ser), ExAC rs756963059, TOPMed rs756963059, gnomAD rs756963059, REVEL 0.53, CADD 24.20
- I40T (p.Ile40Thr), Ensembl rs949659704, MetaLR 0.42, MetaSVM -0.26
- V41F (p.Val41Phe), 1000Genomes rs548362661, ExAC rs548362661, TOPMed rs548362661, gnomAD rs548362661, REVEL 0.56, CADD 23.50
- V41I (p.Val41Ile), cosmic curated COSV65267, 1000Genomes rs548362661, ExAC rs548362661, TOPMed rs548362661, REVEL 0.30, CADD 24.10
- L43P (p.Leu43Pro), Ensembl rs201597057, REVEL 0.79, CADD 27.80
- G44S (p.Gly44Ser), NCI-TCGA Cosmic COSV6526, cosmic curated COSV65266, REVEL 0.53, CADD 26.50, Variant assessed as somatic; moderate impact.
- F45S (p.Phe45Ser), TOPMed rs1783320756, gnomAD rs1783320756, REVEL 0.63, CADD 26.20
- T46I (p.Thr46Ile), ExAC rs755389619, gnomAD rs755389619, REVEL 0.14, CADD 16.30
- T46N (p.Thr46Asn), ExAC rs755389619, gnomAD rs755389619, REVEL 0.47, CADD 22.90
- T46P (p.Thr46Pro), Ensembl rs1583403752
- P47L (p.Pro47Leu), TOPMed rs1181081847, gnomAD rs1181081847, REVEL 0.85, CADD 28.70
- D48A (p.Asp48Ala), ExAC rs766924307, gnomAD rs766924307, MetaLR 0.24, MetaSVM -0.76
- D48G (p.Asp48Gly), ExAC rs766924307, gnomAD rs766924307, REVEL 0.38, CADD 23.70
- H49N (p.His49Asn), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10087, Variant assessed as somatic; moderate impact.
- H49P (p.His49Pro), Ensembl rs1583403736, MetaLR 0.68, MetaSVM 0.59
- R50C (p.Arg50Cys), cosmic curated COSV10087, ExAC rs760698855, TOPMed rs760698855, gnomAD rs760698855, REVEL 0.57, CADD 25.50
- R50H (p.Arg50His), rs773374729, NCI-TCGA Cosmic COSV1008, cosmic curated COSV10087, ExAC rs773374729, REVEL 0.11, CADD 0.14, Variant assessed as somatic; moderate impact.
- R52Q (p.Arg52Gln), rs767569658, NCI-TCGA Cosmic COSV6526, cosmic curated COSV65268, ExAC rs767569658, REVEL 0.04, CADD 7.82, Variant assessed as somatic; moderate impact.
- R52W (p.Arg52Trp), TOPMed rs1783319808, REVEL 0.11, CADD 12.90
- P54S (p.Pro54Ser), rs8177504, UniProt VAR 039322, ExAC rs8177504, TOPMed rs8177504, REVEL 0.37, CADD 22.00
- P54T (p.Pro54Thr), ExAC rs8177504, TOPMed rs8177504, gnomAD rs8177504, REVEL 0.56, CADD 23.30
- G55R (p.Gly55Arg), rs371692503, cosmic curated COSV65266, ESP rs371692503, ExAC rs371692503, REVEL 0.43, CADD 24.30, Variant assessed as somatic; moderate impact.
- A57G (p.Ala57Gly), gnomAD rs1431278103, REVEL 0.23, CADD 21.90
- E58* (p.Glu58Ter), ESP rs138397321, ExAC rs138397321, TOPMed rs138397321, gnomAD rs138397321, CADD 34.00
- E58K (p.Glu58Lys), rs138397321, cosmic curated COSV65267, ESP rs138397321, ExAC rs138397321, REVEL 0.31, CADD 21.50, Variant assessed as somatic; moderate impact.
- E58Q (p.Glu58Gln), ESP rs138397321, ExAC rs138397321, TOPMed rs138397321, gnomAD rs138397321, REVEL 0.16, CADD 16.10
- L59R (p.Leu59Arg), gnomAD rs1249035003, REVEL 0.50, CADD 22.40
- L59V (p.Leu59Val), gnomAD rs1783319053, REVEL 0.39, CADD 22.80
- S60C (p.Ser60Cys), ExAC rs780754617, gnomAD rs780754617, REVEL 0.46, CADD 24.20
- S60I (p.Ser60Ile), ExAC rs756798963, TOPMed rs756798963, gnomAD rs756798963, REVEL 0.48, CADD 24.50
- S60N (p.Ser60Asn), ExAC rs756798963, TOPMed rs756798963, gnomAD rs756798963, REVEL 0.34, CADD 23.90
- S60R (p.Ser60Arg), ExAC rs746655526, gnomAD rs746655526, REVEL 0.17, CADD 15.70
- R62C (p.Arg62Cys), rs1314319598, NCI-TCGA Cosmic COSV6526, cosmic curated COSV65266, TOPMed rs1314319598, REVEL 0.40, CADD 23.30, Variant assessed as somatic; moderate impact.
- R62G (p.Arg62Gly), TOPMed rs1314319598, gnomAD rs1314319598
- R62H (p.Arg62His), rs1017655480, ClinGen CA151164491, ClinVar RCV004261175, TOPMed rs1017655480, REVEL 0.35, CADD 22.60, Uncertain significance, not specified
- R62L (p.Arg62Leu), NCI-TCGA TCGA novel, TOPMed rs1017655480, gnomAD rs1017655480, REVEL 0.40, CADD 22.50, Uncertain significance
- G64C (p.Gly64Cys), rs754226685, NCI-TCGA Cosmic COSV1008, cosmic curated COSV10087, ExAC rs754226685, REVEL 0.54, CADD 25.70, Uncertain significance, not specified
- G64S (p.Gly64Ser), ExAC rs754226685, TOPMed rs754226685, gnomAD rs754226685, REVEL 0.47, CADD 25.00
- S66G (p.Ser66Gly), ExAC rs780501572, gnomAD rs780501572, REVEL 0.56, CADD 24.60
- S66R (p.Ser66Arg), ExAC rs756619790, gnomAD rs756619790
- P67L (p.Pro67Leu), 1000Genomes rs145369394, ESP rs145369394, ExAC rs145369394, TOPMed rs145369394, REVEL 0.08, CADD 0.02
- P67S (p.Pro67Ser), ExAC rs767622094, TOPMed rs767622094, gnomAD rs767622094, REVEL 0.09, CADD 17.50
- P67T (p.Pro67Thr), ExAC rs767622094, TOPMed rs767622094, gnomAD rs767622094, REVEL 0.10, CADD 17.00
- A68V (p.Ala68Val), rs751773139, NCI-TCGA Cosmic COSV6526, ExAC rs751773139, gnomAD rs751773139, REVEL 0.17, CADD 18.20, Variant assessed as somatic; moderate impact.
- E70G (p.Glu70Gly), Ensembl rs80226649
- E70Q (p.Glu70Gln), gnomAD rs1408066869, REVEL 0.15, CADD 20.50
- L71Q (p.Leu71Gln), ExAC rs762784781, gnomAD rs762784781, REVEL 0.61, CADD 23.60
- N72T (p.Asn72Thr), rs775454899, ClinGen CA4084748, ClinVar RCV004335079, ExAC rs775454899, REVEL 0.39, CADD 25.20, Uncertain significance, not specified
- Y73C (p.Tyr73Cys), Ensembl rs1783317446, REVEL 0.33, CADD 24.70
- Y73H (p.Tyr73His), TOPMed rs1160741001, gnomAD rs1160741001, REVEL 0.15, CADD 22.30, Uncertain significance, not specified
- T74A (p.Thr74Ala), TOPMed rs893408492, REVEL 0.43, CADD 25.30
- T74M (p.Thr74Met), rs769783921, NCI-TCGA Cosmic COSV6526, cosmic curated COSV65267, ExAC rs769783921, REVEL 0.66, CADD 26.00, Variant assessed as somatic; moderate impact.
- T74R (p.Thr74Arg), ExAC rs769783921, gnomAD rs769783921, REVEL 0.69, CADD 25.80
- V75M (p.Val75Met), cosmic curated COSV10467, TOPMed rs1783317137, gnomAD rs1783317137, REVEL 0.33, CADD 22.40
- P76L (p.Pro76Leu), ExAC rs776485194, TOPMed rs776485194, gnomAD rs776485194, REVEL 0.68, CADD 23.40
- P76R (p.Pro76Arg), ExAC rs776485194, TOPMed rs776485194, gnomAD rs776485194, REVEL 0.80, CADD 24.70
- G77A (p.Gly77Ala), ESP rs375277138, ExAC rs375277138, TOPMed rs375277138, gnomAD rs375277138
- G77D (p.Gly77Asp), NCI-TCGA TCGA novel, MetaLR 0.44, MetaSVM -0.24, Variant assessed as somatic; moderate impact.
- G77V (p.Gly77Val), cosmic curated COSV10087, ESP rs375277138, ExAC rs375277138, TOPMed rs375277138, REVEL 0.23, CADD 20.40
- P78Q (p.Pro78Gln), gnomAD rs1270581848, REVEL 0.05, CADD 4.44
- P78T (p.Pro78Thr), NCI-TCGA TCGA novel, REVEL 0.09, CADD 10.50, Variant assessed as somatic; moderate impact.
- G79R (p.Gly79Arg), NCI-TCGA Cosmic COSV6526, cosmic curated COSV65267, gnomAD rs1410111608, REVEL 0.27, CADD 22.70, Variant assessed as somatic; moderate impact.
- A81T (p.Ala81Thr), gnomAD rs1321219573, REVEL 0.06, CADD 3.05
- A81V (p.Ala81Val), rs771745592, NCI-TCGA Cosmic COSV6526, cosmic curated COSV65266, ExAC rs771745592, REVEL 0.08, CADD 0.05, Variant assessed as somatic; moderate impact.
- G82D (p.Gly82Asp), rs532711865, ClinGen CA4084738, cosmic curated COSV65265, ClinVar RCV004172012, REVEL 0.07, CADD 7.81, Uncertain significance, not specified
- G82S (p.Gly82Ser), TOPMed rs1783316322, REVEL 0.23, CADD 16.30
- E83* (p.Glu83Ter), ExAC rs750937051, TOPMed rs750937051, gnomAD rs750937051
- E83K (p.Glu83Lys), rs750937051, NCI-TCGA Cosmic COSV6526, cosmic curated COSV65265, ExAC rs750937051, REVEL 0.04, CADD 6.39, Variant assessed as somatic; moderate impact.
- A84G (p.Ala84Gly), gnomAD rs1386277230
- A84P (p.Ala84Pro), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10087, Variant assessed as somatic; moderate impact.
- A84V (p.Ala84Val), gnomAD rs1386277230, MetaLR 0.15, MetaSVM -0.93
- S85P (p.Ser85Pro), cosmic curated COSV65266, gnomAD rs1783315941, REVEL 0.12, CADD 21.40
- P86A (p.Pro86Ala), TOPMed rs1783315886
- P86L (p.Pro86Leu), gnomAD rs1783315829, REVEL 0.06, CADD 7.30
- R87G (p.Arg87Gly), ExAC rs781590898, TOPMed rs781590898, gnomAD rs781590898, REVEL 0.09, CADD 3.88
- R87K (p.Arg87Lys), ExAC rs751710851, gnomAD rs751710851
- R87T (p.Arg87Thr), ExAC rs751710851, gnomAD rs751710851, REVEL 0.07, CADD 5.96
- Q88* (p.Gln88Ter), TOPMed rs1356763306
- Q88H (p.Gln88His), 1000Genomes rs200904655, ExAC rs200904655, TOPMed rs200904655, gnomAD rs200904655, REVEL 0.34, CADD 21.90
- Q88R (p.Gln88Arg), gnomAD rs1195266370
- C89R (p.Cys89Arg), TOPMed rs1783315012
- R90G (p.Arg90Gly), ESP rs148841179, ExAC rs148841179, TOPMed rs148841179, gnomAD rs148841179, REVEL 0.13, CADD 9.68
- R91C (p.Arg91Cys), rs755217303, ClinGen CA4084729, ClinVar RCV004224158, ExAC rs755217303, REVEL 0.39, CADD 22.00, Uncertain significance, not specified
- R91H (p.Arg91His), rs370802129, cosmic curated COSV65265, ESP rs370802129, ExAC rs370802129, REVEL 0.31, CADD 22.40, Variant assessed as somatic; moderate impact.
- R91S (p.Arg91Ser), ExAC rs755217303, TOPMed rs755217303, gnomAD rs755217303, REVEL 0.27, CADD 9.09, Uncertain significance, not specified
- Y92* (p.Tyr92Ter), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10087, NCI-TCGA Cosmic COSV6526, Variant assessed as somatic; high impact.
- E93D (p.Glu93Asp), TOPMed rs1014024980, gnomAD rs1014024980, REVEL 0.06, CADD 11.40
- E93G (p.Glu93Gly), ExAC rs760196452, TOPMed rs760196452, gnomAD rs760196452, REVEL 0.23, CADD 22.70
- E93K (p.Glu93Lys), cosmic curated COSV65266, ExAC rs770799721, gnomAD rs770799721, REVEL 0.31, CADD 15.90
- V94G (p.Val94Gly), Ensembl rs1583403602, MetaLR 0.55, MetaSVM 0.12
- V94M (p.Val94Met), TOPMed rs1273586077, gnomAD rs1273586077, REVEL 0.32, CADD 24.10
- D95H (p.Asp95His), gnomAD rs902306008, REVEL 0.65, CADD 25.50
- D95N (p.Asp95Asn), gnomAD rs902306008
- D95Y (p.Asp95Tyr), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10087, Variant assessed as somatic; moderate impact.
- W96* (p.Trp96Ter), rs896799392, NCI-TCGA Cosmic COSV6526, cosmic curated COSV65267, TOPMed rs896799392, CADD 37.00, Variant assessed as somatic; high impact.
- W96R (p.Trp96Arg), ESP rs368040619, ExAC rs368040619, TOPMed rs368040619, gnomAD rs368040619, REVEL 0.65, CADD 28.60
- Q98H (p.Gln98His), TOPMed rs1297143561, gnomAD rs1297143561, REVEL 0.26, CADD 19.90
- Q98K (p.Gln98Lys), Ensembl rs1783314060
- S99N (p.Ser99Asn), NCI-TCGA Cosmic COSV6526, cosmic curated COSV65266, Variant assessed as somatic; moderate impact.
- S99R (p.Ser99Arg), TOPMed rs1783313955
- T100I (p.Thr100Ile), TOPMed rs1227318683, gnomAD rs1227318683, REVEL 0.12, CADD 14.90
- T100N (p.Thr100Asn), NCI-TCGA TCGA novel, MetaLR 0.10, MetaSVM -1.03, Variant assessed as somatic; moderate impact.
- F101C (p.Phe101Cys), gnomAD rs1783313764, REVEL 0.19, CADD 24.30
- F101L (p.Phe101Leu), TOPMed rs1013323019, gnomAD rs1013323019, REVEL 0.12, CADD 12.60
- D102E (p.Asp102Glu), ExAC rs770164492, TOPMed rs770164492, gnomAD rs770164492, REVEL 0.15, CADD 22.60
- D102N (p.Asp102Asn), rs778603640, NCI-TCGA Cosmic COSV6526, cosmic curated COSV65265, ExAC rs778603640, REVEL 0.09, CADD 1.02, Variant assessed as somatic; moderate impact.
- C103* (p.Cys103Ter), ExAC rs781688839, TOPMed rs781688839, gnomAD rs781688839, CADD 35.00
- V104G (p.Val104Gly), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10087, MetaLR 0.08, MetaSVM -0.98, Variant assessed as somatic; moderate impact.
- V104L (p.Val104Leu), TOPMed rs1426011535, gnomAD rs1426011535, REVEL 0.06, CADD 16.10
- V104M (p.Val104Met), TOPMed rs1426011535, gnomAD rs1426011535, REVEL 0.07, CADD 17.60
- D105A (p.Asp105Ala), cosmic curated COSV65265, Ensembl rs2114875094, MetaLR 0.32, MetaSVM -0.58
- D105N (p.Asp105Asn), ExAC rs753326999, TOPMed rs753326999, gnomAD rs753326999, REVEL 0.12, CADD 21.90
- D105Y (p.Asp105Tyr), ExAC rs753326999, TOPMed rs753326999, gnomAD rs753326999, REVEL 0.48, CADD 25.40
- P106L (p.Pro106Leu), TOPMed rs1168366041, MetaLR 0.20, MetaSVM -0.81, Uncertain significance, not specified
- P106S (p.Pro106Ser), ExAC rs778009554, gnomAD rs778009554, REVEL 0.28, CADD 24.90
- P106T (p.Pro106Thr), ExAC rs778009554, gnomAD rs778009554, REVEL 0.30, CADD 24.70, Uncertain significance, not specified
- L107M (p.Leu107Met), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A108D (p.Ala108Asp), NCI-TCGA Cosmic COSV6526, cosmic curated COSV65267, MetaLR 0.04, MetaSVM -1.03, Variant assessed as somatic; moderate impact.
- A108S (p.Ala108Ser), rs1366541162, NCI-TCGA Cosmic COSV1008, cosmic curated COSV10087, TOPMed rs1366541162, REVEL 0.07, CADD 16.20, Variant assessed as somatic; moderate impact.
- S109N (p.Ser109Asn), TOPMed rs941242974, gnomAD rs941242974, REVEL 0.04, CADD 15.70
- D111G (p.Asp111Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D111Y (p.Asp111Tyr), ESP rs370743058, ExAC rs370743058, TOPMed rs370743058, gnomAD rs370743058, REVEL 0.16, CADD 21.10
- N113D (p.Asn113Asp), ExAC rs765415036, TOPMed rs765415036, gnomAD rs765415036, REVEL 0.14, CADD 15.30, Uncertain significance, not specified
- N113K (p.Asn113Lys), TOPMed rs1347745348, MetaLR 0.18, MetaSVM -0.89
- R114S (p.Arg114Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S115N (p.Ser115Asn), Ensembl rs1562440331, REVEL 0.13, CADD 22.30
- R116C (p.Arg116Cys), rs754756404, NCI-TCGA Cosmic COSV1008, cosmic curated COSV10087, ExAC rs754756404, REVEL 0.26, CADD 23.10, Variant assessed as somatic; moderate impact.
- R116H (p.Arg116His), ExAC rs766277243, gnomAD rs766277243, REVEL 0.17, CADD 9.27
- R116L (p.Arg116Leu), rs766277243, ExAC rs766277243, gnomAD rs766277243, REVEL 0.20, CADD 8.98, Variant assessed as somatic; moderate impact.
- R116P (p.Arg116Pro), ExAC rs766277243, gnomAD rs766277243, REVEL 0.23, CADD 10.70
- P118S (p.Pro118Ser), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10087, REVEL 0.32, CADD 23.60, Variant assessed as somatic; moderate impact.
- L119Q (p.Leu119Gln), Ensembl rs1049671629, MetaLR 0.32, MetaSVM -0.68
- L119R (p.Leu119Arg), Ensembl rs1049671629, REVEL 0.47, CADD 23.30
- L119V (p.Leu119Val), gnomAD rs1783312038, REVEL 0.20, CADD 15.30
- G120A (p.Gly120Ala), gnomAD rs867145320
- G120S (p.Gly120Ser), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10087, REVEL 0.04, CADD 7.31, Variant assessed as somatic; moderate impact.
- G120V (p.Gly120Val), gnomAD rs867145320, MetaLR 0.10, MetaSVM -1.01
- P121L (p.Pro121Leu), ExAC rs773192589, TOPMed rs773192589, gnomAD rs773192589, REVEL 0.40, CADD 24.10, Uncertain significance
- P121R (p.Pro121Arg), rs773192589, ClinGen CA4084706, ClinVar RCV004236266, ExAC rs773192589, REVEL 0.22, CADD 19.80, Uncertain significance, not specified
- C122* (p.Cys122Ter), Ensembl rs2114875012, CADD 26.60
- C122G (p.Cys122Gly), ExAC rs767010128, TOPMed rs767010128, gnomAD rs767010128, REVEL 0.92, CADD 25.20
- C122R (p.Cys122Arg), ExAC rs767010128, TOPMed rs767010128, gnomAD rs767010128, REVEL 0.94, CADD 25.40
Public SLC22A2 analysis runs
- SLC22A2 analysis run — SLC22A2 (976 variants) — completed 2026-08-20